# Comparing The Effect of Tadalafil 5 mg/Day to Sildenafil 25 mg/Day on Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Erectile Dysfunction Patients; and Comparison of Clinical Response

> **NCT05466695** · EARLY_PHASE1 · UNKNOWN · sponsor: **Assiut University** · enrollment: 74 (estimated)

## Conditions studied

- Erectile Dysfunction and Neutrophil Lymphocyte Ratio

## Interventions

- **DRUG:** Tadalafil 5mg/sildenafil 25 mg

## Key facts

- **NCT ID:** NCT05466695
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-08-01
- **Target enrollment:** 74 (ESTIMATED)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05466695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05466695, "Comparing The Effect of Tadalafil 5 mg/Day to Sildenafil 25 mg/Day on Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Erectile Dysfunction Patients; and Comparison of Clinical Response". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05466695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*